Eton Pharmaceuticals Inc. (ETON) Tops Q4 EPS by 5c

Eton Pharmaceuticals Inc. (NASDAQ: ETON) reported Q4 EPS of $0.04, $0.05 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $8.5 million versus the consensus estimate of $8.98 million.

For earnings history and earnings-related data on Eton Pharmaceuticals Inc. (ETON) click here.

You May Also Be Interested In

• Eton Pharmaceuticals (ETON) PT Raised to $65 at H.C. Wainwright
• Eton Pharmaceuticals (ETON) PT Raised to $70 at H.C. Wainwright
• Reading (RDI) Tops Q2 EPS by 4c